A new hayfever drug could help those with severe rhume des foins misery. Grazax uses a pollens de graminĂ©es extract to gradually increase tolerance to pollens de graminĂ©es.
Grazax immunotherapy tablets give long-term relief from grass pollen allergy symptoms according to a medical study conducted by the Section of Allergy and Clinical Immunology at Imperial College London.
A five year clinical trial involving more than 200 personnes souffrant du rhume des foins measured symptĂ´mes d'allergie including days of severe symptoms, quality of life and safety. The conclusion of the research is that Grazax is a safe and effective immunotherapy treatment for grass pollen allergy.
ImmunothĂ©rapie can provide sufferers with years of relief from allergy symptoms. Hayfever symptoms include runny nose, picotement des yeux, Ă©ternuements, itchy throat and face, lethargy.
To be effective Grazax needs to be taken four months before the onset of symptĂ´mes for a period of three years. Grazax is not likely to be available to personnes souffrant du rhume des foins in the UK on the NHS for at least several years. Pharmaceutical company Merck is expected to register Grazax for use in America in 2013.
HayMax™ is a natural way to help with hayfever. HayMax™ traps pollen before it gets inside your body. Moins pollen, moins de rĂ©actions.